Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 01, 2022

SELL
$296.48 - $337.87 $4.83 Million - $5.51 Million
-16,307 Reduced 8.57%
173,906 $56.2 Million
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $4.83 Million - $5.51 Million
-16,307 Reduced 8.57%
173,906 $56.2 Million
Q2 2022

Dec 01, 2022

SELL
$278.73 - $327.27 $1.26 Million - $1.48 Million
-4,530 Reduced 2.33%
190,213 $61.7 Million
Q2 2022

Aug 02, 2022

SELL
$278.73 - $327.27 $1.26 Million - $1.48 Million
-4,530 Reduced 2.33%
190,213 $61.7 Million
Q1 2022

Dec 01, 2022

BUY
$234.69 - $291.66 $79,559 - $98,872
339 Added 0.17%
194,743 $55.8 Million
Q1 2022

May 06, 2022

BUY
$234.69 - $291.66 $79,559 - $98,872
339 Added 0.17%
194,743 $55.8 Million
Q4 2021

Dec 01, 2022

BUY
$224.85 - $279.04 $207,761 - $257,832
924 Added 0.48%
194,404 $53.7 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $207,761 - $257,832
924 Added 0.48%
194,404 $53.7 Million
Q3 2021

Dec 01, 2022

BUY
$221.6 - $272.71 $1.06 Million - $1.31 Million
4,790 Added 2.54%
193,480 $44.7 Million
Q3 2021

Nov 05, 2021

BUY
$221.6 - $272.71 $1.06 Million - $1.31 Million
4,790 Added 2.54%
193,480 $44.7 Million
Q2 2021

Dec 01, 2022

SELL
$180.55 - $233.54 $2.22 Million - $2.88 Million
-12,320 Reduced 6.13%
188,690 $43.3 Million
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $2.22 Million - $2.88 Million
-12,320 Reduced 6.13%
188,690 $43.3 Million
Q1 2021

Dec 01, 2022

BUY
$164.32 - $212.72 $814,698 - $1.05 Million
4,958 Added 2.53%
201,010 $37.6 Million
Q1 2021

Apr 30, 2021

BUY
$164.32 - $212.72 $814,698 - $1.05 Million
4,958 Added 2.53%
201,010 $37.6 Million
Q4 2020

Dec 01, 2022

BUY
$130.46 - $172.63 $373,898 - $494,757
2,866 Added 1.48%
196,052 $33.1 Million
Q4 2020

Feb 03, 2021

BUY
$130.46 - $172.63 $373,898 - $494,757
2,866 Added 1.48%
196,052 $33.1 Million
Q3 2020

Dec 01, 2022

SELL
$146.22 - $169.13 $1.27 Million - $1.47 Million
-8,704 Reduced 4.31%
193,186 $28.6 Million
Q3 2020

Nov 03, 2020

SELL
$146.22 - $169.13 $1.27 Million - $1.47 Million
-8,704 Reduced 4.31%
193,186 $28.6 Million
Q2 2020

Dec 01, 2022

BUY
$136.42 - $164.18 $3.82 Million - $4.59 Million
27,984 Added 16.09%
201,890 $33.1 Million
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $1.4 Million - $1.69 Million
-10,272 Reduced 4.84%
201,890 $33.1 Million
Q1 2020

Apr 24, 2020

SELL
$119.05 - $147.35 $1.31 Million - $1.62 Million
-10,979 Reduced 4.92%
212,162 $29.4 Million
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $1.31 Million - $1.62 Million
12,210 Added 5.79%
223,141 $29.3 Million
Q3 2019

Nov 06, 2019

BUY
$106.79 - $116.16 $708,124 - $770,256
6,631 Added 3.25%
210,931 $23.6 Million
Q2 2019

Aug 09, 2019

BUY
$110.79 - $129.32 $186,570 - $217,774
1,684 Added 0.83%
204,300 $22.6 Million
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $745,331 - $877,309
-6,696 Reduced 3.2%
202,616 $26.3 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $881,511 - $987,559
8,324 Added 4.14%
209,312 $24.2 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $1.35 Million - $1.68 Million
15,688 Added 8.47%
200,988 $0
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $24,148 - $27,714
-319 Reduced 0.17%
185,300 $0
Q1 2018

May 07, 2018

BUY
$74.21 - $87.6 $1.19 Million - $1.41 Million
16,054 Added 9.47%
185,619 $14.4 Million
Q4 2017

Feb 08, 2018

BUY
$81.94 - $87.89 $376,350 - $403,678
4,593 Added 2.78%
169,565 $0
Q3 2017

Nov 13, 2017

SELL
$77.07 - $85.54 $96,645 - $107,267
-1,254 Reduced 0.75%
164,972 $0
Q2 2017

Aug 07, 2017

BUY
N/A
166,226
166,226 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.